Обзор
Novo Holdings is a Denmark-based life sciences investment company that provides equity funding for pre-seed and seed stage biotechnology and pharmaceutical companies. As a principal investor, the firm focuses on early-stage ventures in immunology and life sciences innovation, supporting groundbreaking research and technology development globally.
